Literature DB >> 21045807

FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages.

Wuqiang Fan1, Hidetaka Morinaga, Jane J Kim, Eunju Bae, Nathanael J Spann, Sven Heinz, Christopher K Glass, Jerrold M Olefsky.   

Abstract

The macrophage-mediated inflammatory response is a key etiologic component of obesity-related tissue inflammation and insulin resistance. The transcriptional factor FoxO1 is a key regulator of cell metabolism, cell cycle and cell death. Its activity is tightly regulated by the phosphoinositide-3-kinase-AKT (PI3K-Akt) pathway, which leads to phosphorylation, cytoplasmic retention and inactivation of FoxO1. Here, we show that FoxO1 promotes inflammation by enhancing Tlr4-mediated signalling in mature macrophages. By means of chromatin immunoprecipitation (ChIP) combined with massively parallel sequencing (ChIP-Seq), we show that FoxO1 binds to multiple enhancer-like elements within the Tlr4 gene itself, as well as to sites in a number of Tlr4 signalling pathway genes. While FoxO1 potentiates Tlr4 signalling, activation of the latter induces AKT and subsequently inactivates FoxO1, establishing a self-limiting mechanism of inflammation. Given the central role of macrophage Tlr4 in transducing extrinsic proinflammatory signals, the novel functions for FoxO1 in macrophages as a transcriptional regulator of the Tlr4 gene and its inflammatory pathway, highlights FoxO1 as a key molecular adaptor integrating inflammatory responses in the context of obesity and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21045807      PMCID: PMC3018786          DOI: 10.1038/emboj.2010.268

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

Review 1.  FoxOs in tumor suppression and stem cell maintenance.

Authors:  Karen C Arden
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

2.  Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.

Authors:  WuQiang Fan; Toshihiko Yanase; Hidetaka Morinaga; Taijiro Okabe; Masatoshi Nomura; Hiroaki Daitoku; Akiyoshi Fukamizu; Shigeaki Kato; Ryoichi Takayanagi; Hajime Nawata
Journal:  J Biol Chem       Date:  2007-01-02       Impact factor: 5.157

3.  TLR4 links innate immunity and fatty acid-induced insulin resistance.

Authors:  Hang Shi; Maia V Kokoeva; Karen Inouye; Iphigenia Tzameli; Huali Yin; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

4.  Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity.

Authors:  Francis Kim; Matilda Pham; Ian Luttrell; Douglas D Bannerman; Joan Tupper; Joshua Thaler; Thomas R Hawn; Elaine W Raines; Michael W Schwartz
Journal:  Circ Res       Date:  2007-05-03       Impact factor: 17.367

5.  Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.

Authors:  Takashi Nomiyama; Diego Perez-Tilve; Daisuke Ogawa; Florence Gizard; Yue Zhao; Elizabeth B Heywood; Karrie L Jones; Ryuzo Kawamori; Lisa A Cassis; Matthias H Tschöp; Dennis Bruemmer
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

6.  Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing.

Authors:  Gordon Robertson; Martin Hirst; Matthew Bainbridge; Misha Bilenky; Yongjun Zhao; Thomas Zeng; Ghia Euskirchen; Bridget Bernier; Richard Varhol; Allen Delaney; Nina Thiessen; Obi L Griffith; Ann He; Marco Marra; Michael Snyder; Steven Jones
Journal:  Nat Methods       Date:  2007-06-11       Impact factor: 28.547

7.  Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones.

Authors:  Andrea L Hevener; Jerrold M Olefsky; Donna Reichart; M T Audrey Nguyen; Gautam Bandyopadyhay; Ho-Yin Leung; Matthew J Watt; Chris Benner; Mark A Febbraio; Anh-Khoi Nguyen; Brian Folian; Shankar Subramaniam; Frank J Gonzalez; Christopher K Glass; Mercedes Ricote
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

8.  FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress.

Authors:  Zuzana Tothova; Ramya Kollipara; Brian J Huntly; Benjamin H Lee; Diego H Castrillon; Dana E Cullen; Elizabeth P McDowell; Suzan Lazo-Kallanian; Ifor R Williams; Christopher Sears; Scott A Armstrong; Emmanuelle Passegué; Ronald A DePinho; D Gary Gilliland
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

9.  FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages.

Authors:  Dongming Su; Gina M Coudriet; Dae Hyun Kim; Yi Lu; German Perdomo; Shen Qu; Sandra Slusher; Hubert M Tse; Jon Piganelli; Nick Giannoukakis; Jian Zhang; H Henry Dong
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

10.  Characterization of a protein kinase B inhibitor in vitro and in insulin-treated liver cells.

Authors:  Lisa Logie; Antonio J Ruiz-Alcaraz; Michael Keane; Yvonne L Woods; Jennifer Bain; Rudolfo Marquez; Dario R Alessi; Calum Sutherland
Journal:  Diabetes       Date:  2007-06-11       Impact factor: 9.461

View more
  99 in total

1.  Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1.

Authors:  Jonathan Brown; Huizhi Wang; Jill Suttles; Dana T Graves; Michael Martin
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

2.  Putting the brakes on FOXO1 in fat.

Authors:  Jane J Kim; Wuqiang Fan; Jerrold M Olefsky
Journal:  EMBO J       Date:  2012-04-17       Impact factor: 11.598

3.  Nuclear FoxO1 inflames insulin resistance.

Authors:  John E Dominy; Pere Puigserver
Journal:  EMBO J       Date:  2010-12-15       Impact factor: 11.598

Review 4.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

5.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

6.  FOXO transcription factors in non-alcoholic fatty liver disease.

Authors:  X Charlie Dong
Journal:  Liver Res       Date:  2017-09

7.  Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of β-catenin and FOXO-1.

Authors:  Purnima Gupta; Supriya Srivastav; Shriya Saha; Pijush K Das; Anindita Ukil
Journal:  Cell Death Differ       Date:  2016-09-23       Impact factor: 15.828

Review 8.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 9.  Dysregulation of Hyaluronan Homeostasis During White Matter Injury.

Authors:  Taasin Srivastava; Larry S Sherman; Stephen A Back
Journal:  Neurochem Res       Date:  2019-09-21       Impact factor: 3.996

10.  FoxO1 is a critical regulator of M2-like macrophage activation in allergic asthma.

Authors:  Sangwoon Chung; Ji Y Kim; Min-Ae Song; Gye Y Park; Yong G Lee; Manjula Karpurapu; Joshua A Englert; Megan N Ballinger; Navjot Pabla; Hae Y Chung; John W Christman
Journal:  Allergy       Date:  2018-11-05       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.